"Antibody Formation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.
Descriptor ID |
D000917
|
MeSH Number(s) |
G12.070
|
Concept/Terms |
Antibody Formation- Antibody Formation
- Formation, Antibody
- Antibody Response
- Antibody Responses
- Response, Antibody
- Responses, Antibody
- Antibody Production
- Production, Antibody
|
Below are MeSH descriptors whose meaning is more general than "Antibody Formation".
Below are MeSH descriptors whose meaning is more specific than "Antibody Formation".
This graph shows the total number of publications written about "Antibody Formation" by people in this website by year, and whether "Antibody Formation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 0 | 4 | 4 |
1998 | 0 | 2 | 2 |
2000 | 1 | 1 | 2 |
2001 | 0 | 1 | 1 |
2002 | 1 | 0 | 1 |
2003 | 1 | 2 | 3 |
2004 | 2 | 2 | 4 |
2005 | 0 | 1 | 1 |
2006 | 0 | 2 | 2 |
2007 | 1 | 0 | 1 |
2008 | 3 | 2 | 5 |
2009 | 1 | 2 | 3 |
2010 | 1 | 1 | 2 |
2012 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2017 | 0 | 2 | 2 |
2018 | 0 | 4 | 4 |
2019 | 1 | 1 | 2 |
2021 | 1 | 3 | 4 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibody Formation" by people in Profiles.
-
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapy. JCI Insight. 2023 Mar 22; 8(6).
-
Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice. Front Immunol. 2022; 13:800295.
-
Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. J Cyst Fibros. 2021 11; 20(6):1080-1084.
-
Immunomodulatory regulation by heat-labile enterotoxins and potential therapeutic applications. Expert Rev Vaccines. 2021 08; 20(8):975-987.
-
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses. Immunity. 2021 04 13; 54(4):769-780.e6.
-
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 03 06; 397(10277):881-891.
-
Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes. Vaccine. 2020 01 22; 38(4):942-950.
-
Race-related differences in functional antibody response to pneumococcal vaccination in HIV-infected individuals. Vaccine. 2019 03 14; 37(12):1622-1629.
-
IGHG, IGKC, and FCGR genes and endogenous antibody responses to GARP in patients with breast cancer and matched controls. Hum Immunol. 2018 Aug; 79(8):632-637.
-
Characterization of murine antibody responses to vaccinia virus envelope protein A14 reveals an immunodominant antigen lacking of effective neutralization targets. Virology. 2018 05; 518:284-292.